Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

CONCLUSIONS: Anti-vascular endothelial growth factor agents induce increases in IOP of small and uncertain clinical significance.
TRIAL REGISTRATION NUMBER: ISRCTN92166560.
PMID: 27073205 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - April 11, 2016 Category: Opthalmology Authors: Foss AJ, Scott LJ, Rogers CA, Reeves BC, Ghanchi F, Gibson J, Chakravarthy U, IVAN study group Tags: Br J Ophthalmol Source Type: research